Belgian investor Gimv has invested €30m of growth capital in Swiss medical device company Spineart.
Ylva Hannestad joins GP’s client engagement around sustainability agenda
Technology investor plans to keep up the pace of its existing direct investments pace but expects to see more portfolio sellers
New business, Veld Capital, will raise new funds and also deploy via AnaCap's existing credit funds
Belgian GP expects ‘disruptive scaleup’ consumer investments to weather economic downturn